1. Home
  2. ACON

as 05-29-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Technology

Retail: Computer Software & Peripheral Equipment

Nasdaq

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Founded: 2008 Country:
United States
United States
Employees: N/A City: BROOMFIELD
Market Cap: 2.6M IPO Year: 2022
Target Price: N/A AVG Volume (30 days): 2.7M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.02 EPS Growth: N/A
52 Week Low/High: $0.27 - $25.60 Next Earning Date: 05-15-2024
Revenue: $60,048 Revenue Growth: -21.90%
Revenue Growth (this year): 5.51% Revenue Growth (next year): 316.67%

ACON Daily Stock ML Predictions

Share on Social Networks: